Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile
- Development stage
- Unknown
- Lead developer
- Merck KGaA
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the benzothiazole class. Its molecular formula is C20H16N6S and it has a molecular weight of approximately 372.45 g/mol[1][2][3][8]. It contains a pyrimidine core substituted with both benzothiazole and pyridine moieties via an ethylene bridge. The compound is listed as experimental in drug databases and does not have an established pharmacological action or approved therapeutic use[1]. No detailed mechanism of action or clinical indication has been reported for this molecule.
- Other names
- (2S)-1,3-Benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4-pyrimidinyl)acetonitrile(2S)-1,3-benzothiazol-2-yI{ 21-( 23-pyridin -31 -ylethyllaminollpyrimidi n -41 -y l lethanenitrile345987–15–7
02
Targets
PIM1 (Proviral integration site for moloney murine leukemia virus kinase 1)
Beyond the preview
Go deeper on (2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile.